AZAMUN

This brand name is authorized in Hong Kong SAR China, New Zealand, South Africa.

Active ingredients

The drug AZAMUN contains one active pharmaceutical ingredient (API):

1	Azathioprine UNII MRK240IY2L - AZATHIOPRINE
	Azathioprine is a pro-drug of 6-mercaptopurine (6-MP). 6-MP is inactive but acts as a purine antagonist and requires cellular uptake and intracellular anabolism to thioguanine nucleotides (TGNs) for immunosuppression. The TGNs and other metabolites (e.g. 6-methyl-mecaptopurine ribonucleotides) inhibit de novo purine synthesis and purine nucleotide interconversions.
	Read more about Azathioprine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AZAMUN Film coated tablet	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AX01	Azathioprine	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants
Discover more medicines within L04AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	44747, 65195
NZ	Medicines and Medical Devices Safety Authority	16595, 16596, 16597, 8288
ZA	Health Products Regulatory Authority	36/26/0006